Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma (Q39612017)
Jump to navigation
Jump to search
scientific article published on 25 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma |
scientific article published on 25 March 2011 |
Statements
1 reference
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma (English)
1 reference
Herbert Rübben
1 reference
Hagen S Bachmann
1 reference
Lukas C Heukamp
1 reference
Klaus J Schmitz
1 reference
Caroline F Hilburn
1 reference
Philip Kahl
1 reference
Reinhard Buettner
1 reference
Holger Nückel
1 reference
Andreas Eisenhardt
1 reference
Kurt Werner Schmid
1 reference
Winfried Siffert
1 reference
Angelika Eggert
1 reference
Alexander Schramm
1 reference
Johannes H Schulte
1 reference
25 March 2011
1 reference
1 reference
2390-2399
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference